Jinling Pharmaceutical Company Limited (SHE:000919)

SHE:000919 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,739	4,104	4,023	3,966	3,856	3,876
Market Cap Growth	17.98%	2.02%	1.43%	2.86%	-0.52%	5.34%
Enterprise Value	3,425	2,644	3,503	3,076	3,156	2,918
Last Close Price	7.62	6.49	7.64	7.45	7.23	7.16
PE Ratio	146.99	101.56	37.88	37.67	31.96	59.50
Forward PE	-	20.24	20.24	20.24	20.24	20.24
PS Ratio	1.51	1.25	1.26	1.49	1.37	1.55
PB Ratio	0.98	0.85	0.91	1.09	1.09	1.13
P/TBV Ratio	1.39	1.21	1.47	1.46	1.39	1.47
P/FCF Ratio	28.08	-	-	-	29.83	193.24
P/OCF Ratio	17.22	26.62	18.97	15.22	13.20	12.44
PEG Ratio	-	1.01	1.01	1.01	1.01	1.01
EV/Sales Ratio	1.09	0.81	1.10	1.15	1.12	1.17
EV/EBITDA Ratio	24.37	15.62	15.24	17.72	10.84	9.94
EV/EBIT Ratio	-	104.48	43.33	60.28	18.65	16.80
EV/FCF Ratio	20.29	-	-	-	24.42	145.51
Debt / Equity Ratio	0.04	0.04	0.01	0.00	0.01	-
Debt / EBITDA Ratio	1.35	1.08	0.18	0.03	0.06	-
Debt / FCF Ratio	1.13	-	-	-	0.13	-
Asset Turnover	0.55	0.57	0.64	0.59	0.64	0.59
Inventory Turnover	9.82	9.52	9.45	8.64	9.46	8.64
Quick Ratio	3.40	3.25	2.69	2.72	2.37	2.27
Current Ratio	3.69	3.52	2.98	3.04	2.67	2.56
Return on Equity (ROE)	0.15%	0.39%	3.20%	3.18%	4.39%	2.73%
Return on Assets (ROA)	-0.07%	0.27%	1.01%	0.71%	2.42%	2.57%
Return on Invested Capital (ROIC)	-0.09%	0.48%	3.40%	2.37%	6.35%	6.56%
Return on Capital Employed (ROCE)	-0.10%	0.50%	1.80%	1.40%	4.70%	5.00%
Earnings Yield	0.68%	0.98%	2.64%	2.66%	3.13%	1.68%
FCF Yield	3.56%	-1.16%	-0.64%	-1.24%	3.35%	0.52%
Dividend Yield	1.32%	1.54%	1.31%	1.34%	1.38%	1.40%
Payout Ratio	220.46%	156.50%	48.17%	48.60%	42.00%	138.60%
Buyback Yield / Dilution	-9.53%	-17.56%	-0.01%	0.02%	0.01%	-0.02%
Total Shareholder Return	-8.21%	-16.02%	1.30%	1.36%	1.40%	1.38%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.